Tech Company Financing Transactions
Alder Biopharmaceuticals Funding Round
Sevin Rosen Funds, Ventures West and WRF Capital invested in a $11.1 million Series A venture round for Alder Biopharmaceuticals. The financing round closed on 8/15/2005.
Transaction Overview
Company Name
Announced On
8/15/2005
Transaction Type
Venture Equity
Amount
$11,100,000
Round
Series A
Investors
Proceeds Purpose
This funding will allow us to develop our lead antibody therapeutic, broaden our product pipeline, and build on our proprietary antibody discovery and manufacturing technologies.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
11804 North Creek Pkwy. South
Bothell, WA 98011
USA
Bothell, WA 98011
USA
Phone
Website
Email Address
Overview
Alder focuses on developing its pipeline of therapeutic candidates that leverage its proprietary monoclonal antibody discovery and manufacturing technologies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Azelby
Chief Financial Officer
Carlos Campoy
Chief Medical Officer
Paul Streck
Chief Operating Officer
Erin Lavelle
VP - Bus. Development
Nadia Dac
VP - General Counsel
James Bucher
VP - Operations
Randy Hassler
VP - Regulatory Affairs
Annette Vahratian
Browse more venture capital transactions:
Prev: 8/15/2005: Skytide venture capital transaction
Next: 8/15/2005: CaseStack venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs